Blood bank reagents

Ended Purchase Order Awarded Last action

Contract number
HT940623P0231
Awardee
Awarding agency
Obligated
$36,743

Award facts

Opportunity
Contract value 60% obligated
  • $36,742.92 Current, with exercised options
  • $61,238.20 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Peachtree Corners, GA 30071, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Novation Agreement P00006 $0
Funding Only Action P00005 $12,248
Exercise an Option P00004 $0
Funding Only Action P00003 $12,248
Exercise an Option P00002 $0
Other Administrative Action P00001 $12,248
Original award $0

About this award

The Defense Health Agency awarded a purchase order to Werfen USA LLC for blood bank reagents valued at $61,238.20 on September 30, 2023. No set-aside was used. Performance occurs at Peachtree Corners, Georgia, with an ultimate completion date of September 30, 2028. The order was issued on firm fixed-price terms against a solicitation posted September 11, 2023, with a due date of October 21, 2023.

Quick answers

Who was awarded contract HT940623P0231?

HT940623P0231 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on September 30, 2023.

How much is contract HT940623P0231 worth?

The government has obligated $36,743 on HT940623P0231. Its potential value, with all options, is $61,238.

Was contract HT940623P0231 competed?

The extent of competition for HT940623P0231 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award